Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer
Recruiting · NCT03711890 · Interventional (participants receive a specific treatment) · Lead sponsor: Ohio State University Comprehensive Cancer Center
View the official record on ClinicalTrials.gov →Interventions studied
Laboratory EvaluationOptical Coherence TomographyTherapeutic Conventional Surgery
What this trial is about
This trial studies how well ultra-high resolution optical coherence tomography works in detecting micrometer sized early stage pancreatic cancer in participants with pancreatic cancer. Ultra-high resolution optical coherence tomography may help to accurately identify pancreatic cancer in resected pancreatic specimens.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Immediate surgery cohort: Adult patients with pancreatic cancer or IPMN
- Immediate surgery cohort: Informed consent will be obtained
- Adult patients undergoing pancreatic resection for a presumed IPMN
Exclusion criteria
- Pregnant
Where it is running
1 location listed across 1 US state.
- Ohio State University Comprehensive Cancer Center - Columbus, Ohio, United States